Clinical Trials Directory

Trials / Completed

CompletedNCT05496985

Chinese Validation of the Simplified Evaluation of CONsciousness Disorders(SECONDs)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Hangzhou Normal University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to translate the SECONDs from French into Chinese and assess the validity and reliability of the Chinese version of the SECONDs .

Detailed description

To promote accurate assessments of DoC patients and the development of clinical research on DoC in China, we here propose and validate a version of the SECONDs translated into Mandarin Chinese. Hence, this study aims to assess the concurrent validity (compared with the CRS-R which has already been translated and validated in Mandarin), intra-rater reliability, and inter-rater reliability of the Chinese version of the SECONDs

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSimplified Evaluation of CONsciousness Disorders (SECONDs)All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)

Timeline

Start date
2021-12-20
Primary completion
2022-03-14
Completion
2022-03-14
First posted
2022-08-11
Last updated
2022-08-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05496985. Inclusion in this directory is not an endorsement.